Prioritize and focus resources on LNCB74 (B7-H4 ADC) with a planned IND submission by year-endCash of approximately $75 million expected to fund operations into second half of 2026 BELTSVILLE, Md., ...

Officials confirmed 43 primates escaped from the Alpha Genesis research lab in Yemassee, South Carolina. They haven't been ...

Officials confirmed 43 primates escaped from the Alpha Genesis research lab in Yemassee, South Carolina. They haven't been ...

The Grim Sleeper is coming to A&E Friday at 9 p.m. ET/8 p.m. CT, centering on serial killer Lonnie Franklin Jr., who preyed ...

Additionally, the CAR-M produced pro-inflammatory cytokines and adopted an inflammatory, activated macrophage phenotype upon antigen engagement. In both syngeneic and humanized tumor models, systemic ...

The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...

Celldex Therapeutics has halted work on its solid-tumor-focused bispecific as the biotech prioritizes its work in ...

The Company presented interim results from the TAMARACK study at the European Society for Medical Oncology (ESMO) Congress in September 2024 and expects to have mature median radiographic ...

In the bustling world of e-commerce, AI-generated content is becoming a staple. As it takes center stage, business owners ...